Clinical characteristics and prognostic factors of patients with severe pulmonary hypertension

Korean Circulation Journal

Volumn 37, Issue 6, 2007, Pages 265-270

  Woo, Seok Lee ^a   Kye, Hun Kim ^a   Dae, Ho Jeong ^a   Ki, Hong Lee ^a   Seo, Na Hong ^a   Hyung, Wook Park ^a   Ju, Han Kim ^a   Young, Keun Ahn ^a   Myung, Ho Jeong ^a   Jeong, Gwan Cho ^a   Jong, Chun Park ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Hypertension, pulmonary; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART MUSCLE ISCHEMIA; HUMAN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PULMONARY HYPERTENSION; RISK FACTOR; SURVIVAL; SYSTOLIC BLOOD PRESSURE; VALVULAR HEART DISEASE; WORLD HEALTH ORGANIZATION;

EID: 34447318895     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2007.37.6.265     Document Type: Article

References (30)

1. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's Heart Disease. 7th ed. Philadelphia: Saunders; 2005. p. 1807-42.
2. Boyce PD, Waxman AB. Pulmonary hypertension: work in progress. J Nucl Cardiol 2003;10:413-23.
3. Kawut SM, Palevsky HI. Surrogate end points for pulmonary arterial hypertension. Am Heart J 2004;148:559-65.
4. Sims JM. What's new in pulmonary artery hypertension. Dimens Crit Care Nurs 2003;22:167-70.
5. Simonneau G, Galie N, Rubin LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S.
6. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
7. Chakinala MM. Changing the prognosis of pulmonary arterial hypertension: impact of medical therapy. Semin Respir Crit Care Med 2005;26:409-16.
8. Gibbs JS, Higenbottam TW. Recommendations on the management of pulmonary hypertension in clinical practice. Heart 2001;86 (Suppl I):11-113.
9. Torbicki A, Kurzyna M. Pulmonary arterial hypertension: evaluation of the newly diagnosed patient. Semin Respir Crit Care Med 2005;26:372-8.
10. Humbert M, Nunes H, Sitbon O, Parent F, Herve P, Simonneau G. Risk factors for pulmonary arterial hypertension. Clin Chest Med 2001;22;459-75.
11. Chung SM, Kim SH, Ryu KH, et al. Impact of pulmonary hypertension on the regional right ventricular strain. Korean Circ J 2006;36:578-82.
12. Lee WD, Kim DS, Lee JH, et al. A clinical review of primary pulmonary hypertension. Korean Circ J 2003;33:507-12.
13. Moloney ED, Evans TW. Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome. Eur Respir J 2003;21:720-7.
14. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound inpatients with tricuspid regurgitation. Circulation 1984;70:657-62.
15. Reynolds T. The Echocardiographer's Pocket Reference. 1st ed. Phoenix: Arizona Heart Institute: 1993. p. 152-60.
16. Peterson KL, Nicod P. Catheterization and angiography in pulmonary hypertension. In: Cardiac Catheterization: Methods, Diagnosis and Therapy. 1st ed. Philadelphia: Saunders; 1997. p.401-14.
17. Huszar RJ. Basic Dysrhythmias. 3rd ed. St. Louis: Mosby; 2002.
18. Oh JK, Seward JB, Tajik AJ. The Echo Manual. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1999.
19. Kwak MH, Oh JH, Jeong JO, et al. Role of echocardiography as a screening test in patients with suspected pulmonary embolism. Korean Circ J 2001;31:500-6.
20. de Perrot M, Granton J, Fadel E. Pulmonary hypertension after pulmonary emboli: an underrecognized condition. CMAJ 2006; 174:1706.
21. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004;23:637-48.
22. Fedullo PF, Kerr KM, Auger WR, Jamieson SW, Kapelanski DP. Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med 2000;21:563-74.
23. Schreiber J, Schreiber C, Kachel R, Bittner H. Thromboembolic pulmonary hypertension. Pneumologie 2007;61:123-4.
24. Roig Figueroa V, Herrero Perez A, de la Torre Ferrera N, Hernandez Garcia E, Aller Alvarez JL, Para Cabello J. Iloprost for chronic thromboembolic pulmonary hypertension. Arch Bronconeumol 2004;40:326-8.
25. Rubin LJ. Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents. Am J Respir Crit Care Med 2002;166:1308-9.
26. Hrometz SL, Shields KM. Sildenafil citrate for the treatment of pulmonary hypertension. Drugs Today 2006;42:771-84.
27. Jacobs A, Preston IR, Gomberg-Maitland M. Endothelin receptor antagonism in pulmonary arterial hypertension: a role for selective ET (A) inhibition? Curr Med Res Opin 2006;22:2567-74.
28. McLaughlin VV, Sitbon O, Badesch DB, et al. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005;25:244-9.
29. Stiebellehner L, Petkov V, Vonbank K, et al. Long-term treatment with oral sidelnafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 2003;123: 1293-5.
30. Olsson LG, Swedberg K, Ducharme A, et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction. J Am Coll Cardiol 2006;47: 1997-2004.